Perceptions on hypertension, barriers and facilitators on non-communicable disease prevention in urban Shivamogga: a qualitative study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20234127Keywords:
Barriers, Facilitators, Hypertension, Physical inactivityAbstract
Background: The world’s health care needs are changing drastically due to significant population and demographic impact. The socioeconomic transition in India have influenced the health risk behaviour leading to the increasing burden of obesity, hypertension, diabetes and dyslipidemia. Primary care facilities play a vital role in preventing and controlling NCDs. Objectives were to assess the perceptions of healthy lifestyle behaviours among urban migrants of south India. To qualitatively assess the facilitators and barriers of NCD prevention.
Methods: Study was conducted in urban Shivamogga from May to August 2023 using non-purposive sampling technique. It was a qualitative study design-focus group discussion (FGD). It involves two FGD of 8 members each. One FGD is from urban school and other FGD is from nationalized bank. This study aimed at providing grounded approach to develop an understanding about the perceptions of hypertension (HTN) and facilitators/barriers in obtaining treatment of the same. The data was subjected to brief reading and analysed by segregating the text under different themes. Responses were recorded by audio-taping and translated into codes. The results were obtained after drawing inferences.
Results: Mean age of study participants was 38.8±3.8 years (FGD1) and 36.8±2.6 years (FGD2). They identified stress, nuclear family, physical inactivity, dietary habits and urban living as the causes of hypertension. They perceived that illiteracy, ignorance, work-pressure, time-constraints, home-remedies could be the barriers for seeking treatment of hypertension.
Conclusions: Hypertension has been perceived as a common and serious problem in our community. There was a felt need about awareness campaign and screening of HTN that may help in implementation of prevention and control activities.
Metrics
References
Martinez R, Lloyd Sherlock P, Soliz P, Ebrahim S, Vega E, Ordunez P, et al. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population based study. Lancet Glob Health. 2020;8:e511-23.
Dandona L, Dandona R, Kumar GA, Shukla DK, Paul VK, Balakrishnan K, et al. Nations within a nation: Variations in epidemiological transition across the states of India, 1990-2016 in the global burden of disease study. Lancet. 2017;390:2437-60.
Negi PC, Chauhan R, Rana V, Vidyasagar, Lal K. Epidemiological study of non-communicable diseases (NCD) risk factors in tribal district of Kinnaur, HP: a cross sectional study. Indian Heart J. 2016;68:655-62.
Krishnan A, Mathur P, Kulothungan V, Salve HR, Leburu S, Amarchand R, et al. Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS). BMC Health Serv Res. 2021;21:1-2.
Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID‐19 on noncommunicable disease patients and health systems: a review. J Intern Med. 2021;289(4):450-62.
NCD Risk Factor Collaboration (NCD RisC). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513-30.
Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, et al. Contribution of six risk factors to achieving the 25×25 non communicable disease mortality reduction target: a modelling study. Lancet 2014;384:427-37.
Kusuma S. Perceptions on hypertension among migrants in Delhi, India: a qualitative study. BMC Public Health. 2009;9:267.
Jose NK, Sruthi MV, Rachel J, Jerome K, Vaz C, Saju CR. Barriers and facilitators of noncommunicable disease (NCD) prevention in Kerala: a qualitative study. J Fam Med Prim Care. 2022;11(6):3109.
Beune EJ, Haafkens JA, Schuster JS, Bindels PJ. “Under pressure”: how Ghananian, African-Surinamese and Dutch patients explain hypertension? J Hum Hypertens. 2006;20:946-55.
Dela Cruz F, Galang CB. The illness beliefs, perceptions, and practices of Filipino Americans with hypertension. J Am Acad Nurse Pract. 2008;20:118-27.
Morgan M. The significance of ethnicity for health promotion: patients’ use of anti-hypertensive drugs in inner London. Int J Epidemiol. 1995;1(Suppl1):S79-84.
Powers BJ, Oddone EZ, Grubber JM, Olsen MK, Bosworth HB. Perceived and actual stroke risk among men with hypertension. J Clin Hypertens. 2008;10:287-94.
Reddy KS. India wakes up to the threat of cardiovascular diseases. J Am Coll Cardiol. 2007;50:1370-2.
Government of India: National Programme for Prevention and Control of Diabetes, Cardiovascular Diseases and Stroke (NPDCS). New Delhi. 2008. Available from: https://nhm.gov.in/index1.php? lang=1&level=2&sublinkid=1048&lid=604. Accessed on 12 September 2023.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-23.
Heurtin-Roberts S, Reisin E. The relation of culturally influenced lay models of hypertension to compliance with treatment. Am J Hypertens. 1992;5:787-92.
Vergara C, Martin AM, Wang F, Horowitz S. Awareness about factors that affect the management of hypertension in Puerto Rican patients. Conn Med. 2004;68:269-76.